LifeStance Health Group, Inc. (LFST) Current Ratio
- Current ratio · latest quarter: Value 1.38×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.38× | Current assets / current liabilities. $377.97M ÷ $274.75M ≈ 1.38× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 377.97M USD | Assets, Current |
| Current obligations | 274.75M USD | Liabilities, Current |
| Cash and equivalents | 225.94M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 110.96M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 11.05M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 14.50M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $377.97M | $274.75M | $225.94M | (m) | $110.96M | (m) | $11.05M | $14.50M | 1.38× |
| 2026-03-31 | $355.91M | $239.73M | $194.80M | (m) | $122.92M | (m) | $4.29M | $18.13M | 1.48× |
| 2025-12-31 | $416.20M | $251.96M | $248.64M | (m) | $95.71M | (m) | $6.12M | $14.50M | 1.65× |
| 2025-09-30 | $360.38M | $228.56M | $203.90M | (m) | $121.07M | (m) | $12.21M | $12.69M | 1.58× |
| 2025-06-30 | $358.85M | $242.28M | $188.93M | (m) | $129.48M | (m) | $7.79M | $10.88M | 1.48× |
| 2025-03-31 | $304.63M | $207.38M | $134.34M | (m) | $140.37M | (m) | $7.42M | $9.06M | 1.47× |
| 2024-12-31 | $312.51M | $228.89M | $154.57M | (m) | $131.80M | (m) | $7.24M | $7.25M | 1.37× |
| 2024-09-30 | $287.02M | $217.51M | $102.61M | (m) | $158.16M | (m) | $7.28M | $2.92M | 1.32× |
| 2024-06-30 | $277.75M | $227.66M | $86.97M | (m) | $167.22M | (m) | $9.97M | $2.92M | 1.22× |
| 2024-03-31 | $244.12M | $207.46M | $49.45M | (m) | $175.94M | (m) | $11.94M | $2.92M | 1.18× |
| 2023-12-31 | $225.73M | $202.87M | $78.82M | (m) | $125.41M | (m) | $7.05M | $2.92M | 1.11× |
| 2023-09-30 | $264.25M | $240.87M | $42.60M | (m) | $149.72M | (m) | $10.40M | $2.60M | 1.10× |
| 2023-06-30 | $237.88M | $180.85M | $79.61M | (m) | $121.80M | (m) | $8.04M | $2.60M | 1.32× |
| 2023-03-31 | $212.51M | $181.14M | $68.29M | (m) | $118.38M | (m) | $7.71M | $2.35M | 1.17× |
| 2022-12-31 | $233.22M | $176.00M | $108.62M | (m) | $100.87M | (m) | $12.29M | $2.35M | 1.33× |
| 2022-09-30 | $252.59M | $112.27M | $90.34M | (m) | $113.28M | (m) | $7.95M | $2.15M | 2.25× |
| 2022-06-30 | $244.29M | $111.54M | $96.69M | (m) | $99.74M | (m) | $12.94M | $1.50M | 2.19× |
| 2022-03-31 | $263.30M | $125.60M | $113.99M | (m) | $94.99M | (m) | $15.14M | $1.32M | 2.10× |
| 2021-12-31 | $266.52M | $116.75M | $148.03M | (m) | $76.08M | (m) | $14.15M | $1.32M | 2.28× |
| 2021-09-30 | $328.33M | $105.20M | $212.12M | (m) | $70.06M | (m) | $3.07M | $1.32M | 3.12× |
| 2021-06-30 | $364.06M | $112.56M | $276.19M | (m) | $60.07M | (m) | $9.96M | $1.62M | 3.23× |
| 2020-12-31 | $76.28M | $75.92M | $18.83M | (m) | $43.71M | (m) | $7.69M | $3.74M | 1.00× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |